| Company profile | Synverdis is a family-owned, medium-sized pharmaceutical company engaged in the research, development and production of new active ingredients for the use in oncology.
With its premises in Heidelberg, the company is GMP-certified and holds a manufacturing license.
In addition to the development of manufacturing processes and their validation, the company has also developed in-house analytics over time, which are also offered for external orders.
Extensive preclinical studies and the first clinical trials for an in-house product of Synverdis showed a high potential for applications in tumor therapy.
Fotolon® is a so-called photosensitizer, which selectively accumulates in tumor tissue.
The “green” porphyrin is produced from plant material (chlorophyll) and thus from an inexhaustible source of raw materials according to the guidelines of the pharmaceutical industry under GMP conditions.
|
| Products & Services | – GMP Drug Substance Production
– Research and Development
– Pharmaceutical Analytics
– Custom manufacturing
– Products for Photodynamic Therapy
– Natural drug substances
|
| References and export activities | Hospitals and Pharmacies all over the world
|
| Target group | Pharmaceutical companies
Pharmacies
Hospitals
|
| Competitive advantages | – Flexible Devolpment of drug substances
– Combinations with natural drugs like boswellia and curcumin
– New techniques for Cancer treatment
|
| Ideal Business Partners | – Investors for marketing authorisation of the products
– Pharmaceutical companies with interests in outsourcing pharmaceutical development and/or analytics
– Wholesalers with interest in natural products for intraveneous application
|
